LIFE CLINIC: what changed
LIFE CLINIC
Largest movements
- Cash -€281,183
down €281,183 (-96.5%), from €291,259 to €10,076
mainly Receivables after one year (-€268,003) and Current investments (-€127,665)
- Receivables after one year +€268,003
new in 2025: €268,003
- Financial fixed assets -€127,813
no longer reported in 2025 (was €127,813)
- Current investments +€127,665
new in 2025: €127,665
- Deferred charges and accrued income +€14,988
new in 2025: €14,988
- Debts after one year -€19,840
down €19,840 (-19.7%), from €100,798 to €80,958
- Gross operating margin -€24,657
down €24,657 (-76.4%), from €32,258 to €7,601
- Financial income +€20,174
up €20,174 (+2,923,733%), from €1 to €20,174
- Other operating charges +€5,966
up €5,966 (+513%), from €1,163 to €7,129
- Taxes -€1,868
down €1,868 (-54.4%), from €3,432 to €1,564
- Depreciation -€366
down €366 (-2.4%), from €15,349 to €14,982
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €666,207 | €647,922 | -€18,285 | -2.7% |
| Fixed assets | 21/28 | €305,235 | €162,440 | -€142,795 | -46.8% |
| Tangible fixed assets | 22/27 | €177,423 | €162,440 | -€14,982 | -8.4% |
| Land and buildings | 22 | €176,338 | €162,138 | -€14,200 | -8.1% |
| Plant, machinery and equipment | 23 | €1,022 | €302 | -€720 | -70.5% |
| Furniture and vehicles | 24 | €63 | €0 | -€63 | -100% |
| Financial fixed assets | 28 | €127,813 | - | -€127,813 | |
| Current assets | 29/58 | €360,972 | €485,482 | +€124,510 | +34.5% |
| Amounts receivable after more than one year | 29 | - | €268,003 | +€268,003 | |
| Other amounts receivable | 291 | - | €268,003 | +€268,003 | |
| Amounts receivable within one year | 40/41 | €69,713 | €64,750 | -€4,963 | -7.1% |
| Trade receivables | 40 | €32,115 | - | -€32,115 | |
| Other amounts receivable | 41 | €37,598 | €64,750 | +€27,152 | +72.2% |
| Current investments | 50/53 | - | €127,665 | +€127,665 | |
| Cash at bank and in hand | 54/58 | €291,259 | €10,076 | -€281,183 | -96.5% |
| Deferred charges and accrued income | 490/1 | - | €14,988 | +€14,988 | |
| Total equity and liabilities | 10/49 | €666,207 | €647,922 | -€18,285 | -2.7% |
| Equity | 10/15 | €532,564 | €534,049 | +€1,485 | +0.3% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €500,262 | €500,262 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,855 | €1,855 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,855 | €1,855 | = | 0.0% |
| Distributable reserves | 133 | €498,407 | €498,407 | = | 0.0% |
| Profit (loss) carried forward | 14 | €19,902 | €21,388 | +€1,485 | +7.5% |
| Amounts payable | 17/49 | €133,643 | €113,873 | -€19,770 | -14.8% |
| Amounts payable after more than one year | 17 | €100,798 | €80,958 | -€19,840 | -19.7% |
| Financial debts | 170/4 | €100,798 | €80,958 | -€19,840 | -19.7% |
| Amounts payable within one year | 42/48 | €32,846 | €32,915 | +€70 | +0.2% |
| Current portion of amounts payable after more than one year | 42 | €19,537 | €19,840 | +€303 | +1.5% |
| Trade debts | 44 | €12,783 | €10,759 | -€2,024 | -15.8% |
| Suppliers | 440/4 | €12,783 | €10,759 | -€2,024 | -15.8% |
| Taxes, remuneration and social security | 45 | €526 | €1,721 | +€1,195 | +227% |
| Taxes | 450/3 | €526 | €1,721 | +€1,195 | +227% |
| Other amounts payable | 47/48 | - | €595 | +€595 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €15,349 | €14,982 | -€366 | -2.4% |
| Other operating charges | 640/8 | €1,163 | €7,129 | +€5,966 | +513% |
| Gross operating margin | 9900 | €32,258 | €7,601 | -€24,657 | -76.4% |
| Operating profit (loss) | 9901 | €15,746 | -€14,510 | -€30,257 | |
| Financial income | 75/76B | €1 | €20,174 | +€20,174 | +2,923,733% |
| Recurring financial income | 75 | €1 | €20,174 | +€20,174 | +2,923,733% |
| Financial charges | 65/66B | €2,836 | €2,615 | -€221 | -7.8% |
| Recurring financial charges | 65 | €2,836 | €2,615 | -€221 | -7.8% |
| Profit (loss) for the period before taxes | 9903 | €12,911 | €3,050 | -€9,862 | -76.4% |
| Income taxes | 67/77 | €3,432 | €1,564 | -€1,868 | -54.4% |
| Profit (loss) for the period | 9904 | €9,479 | €1,485 | -€7,993 | -84.3% |
| Profit (loss) for the period to be appropriated | 9905 | €9,479 | €1,485 | -€7,993 | -84.3% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 8 November 2026 via checked.be.